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In order to delineate the location of the tumor both before and during operation, we developed targeted bi-functional
polymeric micelles for magnetic resonance (MR) and fluorescence imaging in liver tumors. Hydrophobic superparamagnetic
iron oxide nanoparticles (SPIONs) were loaded into the polymeric micelles through self-assembly of an amphiphilic block
copolymer poly(ethylene glycol)-poly(ε-caprolactone). After, transferrin (Tf) and near-infrared fluorescence molecule Cy5.5
were conjugated onto the surface of the polymeric micelles to obtain the nanosized probe SPIO@PEG-b-PCL-Tf/Cy5.5
(SPPTC). Imaging capabilities of this nanoprobe were evaluated both in vitro and in vivo. The accumulation of SPPTC in
HepG2 cells increased over SPIO@PEG-b-PCL-Cy5.5 (SPPC) by confocal microscopy. The targeted nanoprobe SPPTC
possessed favorable properties on the MR and fluorescence imaging both in vitro and in vivo. The MTT results showed
that the nanoprobes were well tolerated. SPPTC had the potential for pre-operation evaluation and intra-operation
navigation of tumors in clinic.
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Magnetic resonance imaging (MRI) has been extensively
used in the diagnosis of human cancers for its high
spatial resolution [1]. However, it is not sensitive enough
to delineate the boundary of tumor clearly. On the other
hand, optical imaging, especially near-infrared fluores-
cence imaging, offers high sensitivity [2,3]. Nevertheless,
the low spatial resolution of optical imaging limits its
applications in clinical fields [4]. Thus, the combination
of MRI and optical imaging can compensate for these
drawbacks and provide images of the tumor at both
pre-surgical planning stage and surgical resection stage.
Such dual modal imaging will fill the gap between pre-
operative imaging and intra-operative reality. Superpara-
magnetic iron oxide nanoparticles (SPIONs) are the
well-known MRI contrast agent which can be used to
monitor in vivo events [5]. Among various fluorescence* Correspondence: zhuwenzhen@hotmail.com; yhzhu@mail.hust.edu.cn
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in any medium, provided the original work is pdyes, quantum dots as excellent fluorescent dyes were lim-
ited by their toxicity [6]. Near-infrared (NIR) fluorescence
molecule Cy5.5 had been widely utilized in biomedical
fields for its high molar absorption coefficient and fluores-
cence quantum yield, except for its good biocompatibility
[7]. Therefore, the nanoparticle which contained SPIO
and Cy5.5 may be used as a MR/fluorescence imaging
contrast agent.
The optimization of both magnetic and fluorescence
properties within a single probe is the key point because
only improvement of either property seems to impair the
other. In order to balance the fluorescence property and
magnetic property in the probe, the certain interval
between the emitting species and the magnetic material is
of great importance [8]. Due to the short interval between
the emitting species and the magnetic one, the fluorescence
of the fluorophore would be strongly reduced or even
quenched [9,10]. Therefore, different measures were taken
to produce an interval between the fluorophore and mag-
netic one to obtain MR/fluorescence dual imaging probe.
He et al. constructed a nanoprobe of silica-coated iron
oxide, on which the surface was modified with fluorescencepen Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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the fluorescence from SPIO's interference. Chen et al. re-
ported that PLL-capped SPIO-PAA modified with NIR797
was used for MRI/fluorescence imaging [12]. PLL pro-
duced the interval between the SPIO and fluorescence
molecule NIR797 in the nanoparticle. Therefore, it needs
to control the interval between the emitting species and
the magnetic materials to obtain a MR/fluorescence im-
aging probe.
Among a plurality of nanoparticulate systems, the poly-
meric micelle that formed through self-assembly of
amphiphilic block copolymers has a core-shell structure.
Its hydrophobic core serves as a natural carrier environ-
ment for hydrophobic drugs and the hydrophilic shell al-
lows the particles' stability in an aqueous solution [13].
The stabilization of the polymeric micelles increases the
circulation time in vivo and favors the preferential accu-
mulation in tumors because of the enhanced permeability
and retention (EPR) effect [14]. Moreover, the integration
of PEG into the polymer micelles can reduce protein ad-
sorption and limit immune recognition so as to increase
the serum half-life of the nanoprobe in vivo [15].
Targeted delivery is an attractive strategy to further
improve nanoparticle accumulation in tumor tissues and
reduce side effects [16]. Transferrin (Tf) is one of the
most widely used tumor-targeted ligands because Tf re-
ceptors (TfRs) are over-expressed on malignant cells and
play a key role in cellular iron uptake through the inter-
action with Tf [17]. Moreover, the expression level of
TfRs has been suggested to correlate with tumor stage
or cancer progression [18-20].
To guide tumor excision, a tumor-targeted nanoprobe
with the potential for pre-operation evaluation and intra-
operation navigation is required to substantially improve
the accuracy of surgical resection. Here we developed a
water-dispersible hybrid nanoprobe wherein hydrophobic
SPIONs were loaded into polymeric micelles through self-
assembly of an amphiphilic block copolymer poly(ethylene
glycol)-poly(ε-caprolactone) (PEG-b-PCL). Tf and Cy5.5
were conjugated onto the surface of the micelles to con-
struct a targeted bi-functional probe SPIO@PEG-b-PCL-
Tf/Cy5.5 (SPPTC). Then, the potential of the nanoprobe
in MR and fluorescence imaging of tumors both in vitro
and in vivo was evaluated.
Methods
Materials
All materials were purchased from commercial sup-
pliers and used without further purification, unless
otherwise noted. Cy5.5-NHS was purchased from GE
Healthcare (Piscataway, NJ, USA). Succinimidyl iodoa-
cetate (SIA), 2-iminothiolane hydrochloride (Traut's re-
agent), albumin from bovine serum (BSA), and Tf were
purchased from Sigma-Aldrich (St. Louis, MO, USA).Methoxy-PEG5000-b-PCL15000 was purchased from Daigang
Biomaterial Co., Ltd. (Jinan, Shandong, China). NH2-
PEG5800-b-PCL19000 was purchased from Polymer Source
Inc. (Montreal, Quebec, Canada). Other chemicals and re-
agents used in the study were of analytical grade.
All cell lines were preserved in our lab. BALB/c nude mice
(male, 4 to 6 weeks) were purchased from Hunan Slake
Jingda Experimental Animal Co. Ltd., Changsha, China
(Animal Qualification Certification No. 43004700000595).
All animal studies were approved by the Animal Experi-
mentation Ethics Committee of College of Life Science
and Technology, Huazhong University of Science and
Technology and carried out in compliance with the guide-
lines approved by the Science and Technology Department
of Hubei Province.
Preparation of SPPTC
SPIONs were synthesized through the thermal decom-
position method described previously [21]. SPIO-loaded
polymeric micelles were prepared through a solvent eva-
poration method. Briefly, 6 mg of PEG-b-PCL (a mixture
of mPEG-b-PCL and NH2-PEG-b-PCL (5:1)) and SPIONs
(18 mg) were dissolved in THF (3 mL). Then the obtained
solution was added slowly into 20 mL of distilled water in a
dropwise manner under vigorous ultrasonic agitation. After,
the beaker was exposed to air overnight, allowing eva-
poration of THF and formation of micelles slowly so as to
obtain SPIO@PEG-b-PCL. A concentration of Cy5.5-NHS
was adjusted to 20 mg/mL in DMSO. Cy5.5-NHS solution
of 1.5 μL was added to 20 mL of the prepared SPIO@PEG-
b-PCL solution, shaken for 2 h at room temperature. Then
SIA (0.08 mg) in 40 μL DMSO was added to the Cy5.5 con-
jugated micelles and kept in the dark at room temperature
for 2 h. The product was washed three times with and dis-
solved in distilled water (solution 1). Amount of 70 μL of a
Traut's reagent (2 mg/mL) in sodium borate (0.15 M, pH
8.5) was added into 200 μL of 10 mg/mL Tf solution (20
mg, dissolved in 200 μL of 0.15 M sodium borate, pH 8.5)
and kept at 4°C for 2 h (solution 2). Last, solution 1 was
mixed with solution 2 and reacted at 4°C overnight. The
final product was separated using a magnet by removing
the supernatant.
Characterization of SPPTC
The size and the morphology of SPPTC were character-
ized through transmission electron microscopy (TEM,
JEM-2010, JEOL, Tokyo, Japan) at 200 kV. One drop of
the sample solution (0.1 mg/mL) was deposited on a
carbon-coated copper grid (200 meshes) and allowed to
air dry. The excess solution was removed with filter
paper. The hydrodynamic diameter and the size distribu-
tion of SPPTC were measured through dynamic light
scattering (DLS, Zetasizer Nano ZS90, Malvern Instru-
ments Ltd., Worcestershire, UK) at room temperature.
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magnetometer (VSM, ADE Model 4 HF VSM, ADE,
Lowell, MA, USA) under the field of up to 15 kOe
at room temperature. To determine the relaxivity, the
nanoprobe was diluted in distilled water at an iron con-
centration range of 0 to 25 μg/mL. The samples were
transferred to a 96-well plate, and T2 relaxation time was
determined using a whole-body MR scanner (Signa HDx
3.0 T, GE, New York, NY, USA). The fluorescence pro-
perties were determined with IVIS® Lumina XR Imaging
System (Caliper Life Sciences, Hopkinton, MA, USA).
In vitro study
HL7702 cell line (normal human liver cell line) and HepG2
cell line (human liver tumor cell line) were cultured in
DMEM (Gibco, Grand Island, NY, USA) and supple-
mented with 10% fetal bovine serum (Gibco, Grand Island,
NY, USA), penicillin (100 mg/mL), and streptomycin (100
mg/mL) in a humidified atmosphere with 5% CO2 at 37°C.
Reverse transcription-polymerase chain reaction analysis
of TfR1
The PCR primers of TfR1 and GAPDH were designed ac-
cording to the literature [22]. The TfR1 expression level
was determined in HepG2 cell and HL7702 cell. The
mRNA of GAPDH was used as the control in each test
cell line. PCR consisted of initial denaturation at 94°C for
3 min; 30 three-step cycles at 94°C for 1 min, 53°C for 1
min, and 72°C for 1 min; and a final extension at 72°C for
10 min.
In vitro MRI imaging
HL7702 cells and HepG2 cells were incubated with
SPPTC at different iron concentrations (0, 5, 10, 15, 20,
and 25 μg/mL) at 37°C for 2 h. After, the cells were
washed with PBS (0.1 M, pH 7.4) three times and dis-
persed in PBS, and then the cells were dispersed with
350 μL of 1% agarose gel per sample for MRI with 3.0-T
whole-body MR scanner.
In vitro fluorescence imaging
The cellular uptake of SPPTC was determined using
confocal microscope. The HepG2 cells were inoculated
in 6-well plates at a density of 1 × 105 cells per well and
cultured at 37°C overnight. After washing with PBS, the
cells were incubated with SPIO@PEG-b-PCL-Cy5.5
(SPPC) and SPPTC (Fe, 20 μg/mL), respectively, for 2 h
in a CO2 incubator. After incubation, the cells were
washed with PBS three times to remove the remaining
nanoprobes and fixed in a 4% formaldehyde/PBS solu-
tion for 20 min. Then the fixative was removed with
PBS. The fluorescence imaging results were obtained
through a Leica laser scanning confocal microscope
(Leica TCS-SP5, Leica, Wetzlar, Germany).In vivo studies
Induction of subcutaneous HepG2 tumor
Male BALB/c nude mice bearing subcutaneous HepG2
tumor xenografts were used as models. The subcutane-
ous xenografts were generated by subcutaneously inject-
ing 6 × 106 HepG2 cells into the back leg of the nude
BALB/c mouse. The mice were used for the following
imaging analyses when the tumors reached a diameter of
approximately 1 cm.
In vivo fluorescence imaging
The nude mice bearing the tumor were assessed for
Cy5.5 emission at a wavelength of 640 nm after intraven-
ous injection of SPPC or SPPTC suspension (10 mg/kg
Fe of body weight). During fluorescence imaging, mice
(n =6) were anesthetized using gas with a mixture of
oxygen and isoflurane (Hebei Jiupai Pharmaceuticals,
Shijiazhuang, Hebei, China). The images were taken at
different time points (0, 4, and 8 h) after intravenous in-
jection of SPPC or SPPTC. The images were captured
using IVIS® Lumina XR Imaging System.
In vivo MRI
The animals were scanned under Intera 3.0 T MR scanner
(Philips, Amsterdam, Netherlands) after fluorescence im-
aging. The T2-weighted echo images were acquired before
and after nanoprobes' administration. The following pa-
rameters were used: field of view (FOV) =120 mm; base
resolution =192 × 160; repetition time (TR) =2,000 ms;
echo time (TE) =20, 40, 60, 80, 100, 120, and 140 ms; slice
thickness =1.5 mm. The MRI T2 signal intensities within
the region of interest (ROI) and noise signal were mea-
sured before and after administration of the probe. The









After MR imaging, each group of the mice was sacri-
ficed and the tumor tissues were further processed for
Prussian blue staining.
Prussian blue staining
The tumor tissues were fixed in 10% formalin and cryo-
protected with 18% sucrose solution. The sections were
incubated for 30 min in a solution of 2% potassium
ferrocyanide and 2% hydrochloric acid at a 1:1 ratio.
After Prussian blue staining, the sections were counter-
stained with 1% nuclear fast red solution.
Cell toxicity
Normal human liver HL7702 cells (HL7702) were used
for cytotoxicity study. Briefly, the HL7702 cells were
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tachment. After then, a medium containing SPPTC was
added in a dilution series (medium containing 0, 15, 30,
45, and 60 μg/mL Fe). The culture medium was added into
the control well. After 24, 48 and 72 h of incubating the
cells with the materials, 20 μL of 3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium bromide (MTT) (5 mg/mL)
was added to each well. After incubation for 4 h, the
formazan crystals were solubilized with 150 μL of DMSO.
The absorbance of each well was measured using a mi-
croplate reader (1420 multilabel counter, PerkinElmer,
Waltham, MA, USA) at 490 nm to determine the relative
cell viability.
Statistical analysis
Statistical analysis was performed using student's t-test
using statistical software (SPSS 13.0, Chicago, IL, USA). A
difference of p <0.05 was considered statistically significant.
Results and discussion
Construction and characterization of nanoprobe
From the transmission electron microscope images, the
average size of Fe3O4 nanoparticles (SPIONs) preparedFigure 1 Characterization of SPPTC. TEM images of SPIO (a); TEM image
distribution of SPPTC about 196 nm with PDI 0.168 (c). The saturation magthrough thermal decomposition method was about 10.2
nm (Figure 1a). After the SPIONs were being encapsu-
lated into the micelles, the size of SPIO@PEG-b-PCL
was approximately 169.3 nm (Figure 1b). The results of
DLS showed that the hydrodynamic diameter of the
SPIO@PEG-b-PCL was about 196 nm with PDI of 0.168
(data not shown). The hydrodynamic diameter of the
micelles increased (approximately 274 nm) after being
conjugated with Cy5.5 and Tf (Figure 1c).
Magnetic and fluorescence properties of SPPTC
Magnetic properties were important parameters for an
MRI contrast agent. The magnetization of SPPTC was
measured at room temperature. At 300 K, SPPTC exhib-
ited superparamagnetic behaviors, with zero coercivity
and remanence. The saturation magnetization of the ma-
terial was 85.4 emu/g (Figure 1d). In addition, the MR im-
aging capabilities of SPPTC and SPPC were evaluated at
3.0 T through acquiring phantom MR images of the agar-
ose sample. The signal intensity of SPPTC and SPPC
decayed significantly with the increasing iron concentra-
tion (Figure 2a). The relaxivities of SPPTC and SPPC were
196.5 and 219.1 mM−1 s−1 respectively, both showing as of SPPTC through negative staining (b); hydrodynamic size
netizations (Ms) of SPPTC was 85.4 emu/g Fe at 300 K (d).
Figure 2 Magnetic and fluorescent properties of SPPTC. The r2 of SPPTC is 196.5 mM−1 s−1 and the r2 of SPPC is 219.1 mM−1 s−1 at 300 K
respectively (a); the correlation between fluorescence intensity and the concentration of the nanoprobe (b).
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due to the cluster of SPIO formed in the micelles. Ai et al.
had reported that a cluster of SPIO particles had much
higher T2 relaxivity compared the T2 relaxivity of single
SPIO [23]. The fluorescence intensity increased along with
the increase of the nanoprobe concentration (Figure 2b).
It demonstrated that the fluorescence was protected from
the bleaching of SPIO because of the interval produced
by PEG-b-PCL. The results indicated that the magnetic/
fluorescence micelles could function as an efficient im-
aging probe.
TfR1 expression analysis
The evaluation of the TfR1 expression level in HL7702
and HepG2 cells was carried out by reverse transcription-
polymerase chain reaction (RT-PCR). The results showed
that the expression of TfR1 mRNA in the HepG2 cell line
was obvious but there was almost no expression in the
normal cell line HL7702 (Additional file 1: Figure S1). The
TfR family includes TfR1 and TfR2. The affinity of TfR1
for Tf is approximately 30-fold higher than the affinity of
TfR2 [18]. Most cells can effectively control iron uptake by
regulating TfR1 expression [17]. Iron overload conditions
contribute to several pathological conditions including
iron overload-related hepatic cancer [24]. The TfR expres-
sion level is often higher in the tumor tissue than thenormal tissue [20]. Therefore, Tf can be used as the ligand
for targeting liver tumor.In vitro studies
From the MR imaging, significant gradual MR signal de-
cays in HepG2 cells along with the increasing iron concen-
tration when the HepG2 cells were treated with SPPTC or
SPPC. However, the signal in the cells treated with SPPTC
decayed much greater than that of the cells treated with
SPPC at the same iron concentration (Figure 3a). The
strong fluorescence signal could be observed throughout
the cytoplasm in HepG2 cells when treated with SPPTC,
while a weak fluorescence signal existed in the HepG2
cells treated with SPPC (Figure 3b). Therefore, SPPTC can
be used as MR/fluorescence imaging contrast agent in
HepG2 cell.
The nanoprobes with magnetic and fluorescence prop-
erties are of special interest in monitoring and manipulat-
ing at the same time. Chen et al. reported a nanoprobe in
which NIR979 conjugated onto the surface of PLL-capped
SPIO-PAA nanoparticle was used for dendritic cell track-
ing [12]. Wen et al. reported cationic polymersomes
loaded with SPIONs and QDs were used to label neural
stem cells [25]. Gollavelli et al. reported dual model mag-
netic and fluorescence imaging of fluorescent grapheme
Figure 3 The uptake of SPPC or SPPTC in HepG2 cell at different concentrations (Fe). Detected through MRI (a); detected by confocal
microscope (b).
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to detect liver tumor cell.
In vivo studies
The in vivo fluorescence images at the pre- and post-
injection were shown in Figure 4. At different time pointsFigure 4 Fluorescence imaging of SPPTC in mice bearing the subcuta
bottom row, injected with SPPTC.after intravenous injection of SPPTC, strong fluorescence
signals could be observed at the tumor site, while no sig-
nificant fluorescence could be detected at the tumor site
after injection with SPPC. Besides the site of tumor, the
fluorescence signal can be detected at the region of liver or
spleen after being taken out of the mice (Additional file 2:neous tumor at different time points. Top row, injected with SPPC;
Figure 5 T2-weighted MR imaging and Prussian blue staining. In vivo T2-weighted MR imaging before and after intravenous injection of
SPPC or SPPTC (a); the histological sections of tumor with Prussian blue staining (b).
Figure 6 Viabilities of HL7702 cells treated with SPPTC.
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the reticuloendothelial system (liver or spleen). The ability
of SPPTC as a MRI contrast agent was further assessed in
the mouse model. The MR images of the tumor site dis-
played significant contrast enhancement after treated with
SPPTC (Figure 5a). The MR signal intensity at the tumor
site decayed up to 54% in SPPTC-treated mice compared
to the pre-injection MR images, while it was 16% in the
SPPC group (data not shown). To further verify the accu-
mulation of SPPTC at the tumor site, tumor tissue slices
were stained with Prussian blue for ferric ions and by a nu-
clear fast red solution for the cell nucleus. As shown in
Figure 5b, the accumulation of SPIONs could be clearly
observed in the tumor tissues. In contrast, no apparent ac-
cumulation was detected in the SPPC-treated group.
Surgery remains the gold standard for clinical treatments
of most tumors, but resection bears the potential risk of
incomplete excision due to the invasiveness of the malig-
nant tumor. The most important potential application of
the dual MR/fluorescence imaging nanoprobe is to provide
help in pre-operation evaluation and intra-operation navi-
gation in clinic. There are a variety of approaches for the
synthesis of nanoparticles with fluorescent and magnetic
properties. Ni et al. reported an upconversion nanoprobe
(ANG/PEG-UCNPs) for MR/fluorescence imaging of glio-
blastoma in mice [27]. Zhang et al. reported a dual func-
tional nanoprobe to which anti-EGFR mAb and Cy5.5were conjugated onto PEG-coated Fe3O4 nanocrystals was
used to detect the mouse mammary tumor [28]. In our
previous work, we had constructed the pH-/temperature-
sensitive magnetic nanogels conjugated with Cy5.5-labeled
lactoferrin for MR and fluorescence imaging of glioma in
rats [29]. Veiseh et al. reported an iron oxide nanoparticle
coated with a PEGylated chitosan-branched copolymer to
which chlorotoxin and Cy5.5 were conjugated for brain
tumor imaging [15]. As far as we know, there are few
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Tf and Cy5.5 on the surface and provided for dual model
imaging in liver tumor.
Cell toxicity studies
The excellent biocompatibility of SPPTC was verified
in vitro. From Figure 6, no significant change of activity
in the normal liver cell line (HL7702 cell line) was found
when the cells were incubated with SPPTC at a concen-
tration range of 0 to 60 μg/mL (Fe concentration).
Conclusions
In the present study, the magnetic/fluorescence polymeric
micelles are easily prepared and well-tolerated and remain
favorable MRI and fluorescence imaging ability both
in vitro and in vivo. Therefore, SPPTC had the potential
application in pre-operation evaluation by MR imaging
and guiding of tumor resection by intra-operative fluores-
cence imaging.
Additional files
Additional file 1: Figure S1. Expression of TfR1 in HepG2 cell not in
normal liver cell HL7702. GAPDH was used as the control.
Additional file 2: Figure S2. Fluorescence images of different organs
after injection of SPIO@PEG-b-PCL-Tf/Cy5.5 at 24 h.
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